The Janus kinase (JAK)/STAT pathway is important to cell development and differentiation; defects can lead to inhibition of growth restraint, with prolactin implicated in the pathogenesis of human breast cancer (Clevenger et al. 2003). Here, PRL is linked to breast carcinoma.